Balyasny Asset Management
CLLS

Balyasny Asset Management’s Cellectis CLLS Stock Holding History

Balyasny Asset Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,400
Closed -$552K – 2081
2017
Q3 		$552K Buy
+19,400
New +$502K ﹤0.01% 1331

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Balyasny Asset Management's CLLS Position: Q4 2022 in Review

Balyasny Asset Management sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 18,352 shares — an estimated $42K sold.

Balyasny Asset Management first reported a position in CLLS in Q4 2015 and held it in 5 quarters. The position peaked at $11.9M in Q4 2017. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.

  • Balyasny Asset Management reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 18,352 Cellectis shares in Q4 2022, an estimated $42K.
  • Balyasny Asset Management first reported a position in Cellectis in Q4 2015 and held it in 5 quarters.
  • Balyasny Asset Management's Cellectis position peaked at $11.9M in Q4 2017.
  • 40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.